These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21510226)

  • 21. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease.
    Lee JY; Kim JM; Kim JW; Cho J; Lee WY; Kim HJ; Jeon BS
    Parkinsonism Relat Disord; 2010 Mar; 16(3):202-7. PubMed ID: 20018549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The link between Parkinson's and...gambling?
    Johns Hopkins Med Lett Health After 50; 2009 Aug; 21(6):6-7. PubMed ID: 19722312
    [No Abstract]   [Full Text] [Related]  

  • 23. Disabling repetitive behaviors in Parkinson's disease.
    Kurlan R
    Mov Disord; 2004 Apr; 19(4):433-7. PubMed ID: 15077241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impulse control disorders and dopaminergic treatments in Parkinson's disease.
    Villa C; Pascual-Sedano B; Pagonabarraga J; Kulisevsky J
    Rev Neurol (Paris); 2011 Nov; 167(11):827-32. PubMed ID: 21596410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological gambling secondary to dopaminergic therapy in Parkinson's disease.
    Drapier D; Drapier S; Sauleau P; Derkinderen P; Damier P; Allain H; Vérin M; Millet B
    Psychiatry Res; 2006 Nov; 144(2-3):241-4. PubMed ID: 17011634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease].
    Ardouin C; Chéreau I; Llorca PM; Lhommée E; Durif F; Pollak P; Krack P;
    Rev Neurol (Paris); 2009 Nov; 165(11):845-56. PubMed ID: 19683776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy.
    O'Sullivan SS; Djamshidian A; Ahmed Z; Evans AH; Lawrence AD; Holton JL; Revesz T; Lees AJ
    Mov Disord; 2010 Apr; 25(5):638-42. PubMed ID: 20213825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
    Merims D; Giladi N
    Parkinsonism Relat Disord; 2008; 14(4):273-80. PubMed ID: 17988927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impulsive and compulsive behaviors in Parkinson's disease: a one-year follow-up study.
    Ávila A; Cardona X; Martín-Baranera M; Bello J; Sastre F
    J Neurol Sci; 2011 Nov; 310(1-2):197-201. PubMed ID: 21683375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Internet gambling and other pathological gambling in Parkinson's disease: a case series.
    Wong SH; Cowen Z; Allen EA; Newman PK
    Mov Disord; 2007 Mar; 22(4):591-3. PubMed ID: 17266073
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.
    Voon V; Hassan K; Zurowski M; de Souza M; Thomsen T; Fox S; Lang AE; Miyasaki J
    Neurology; 2006 Oct; 67(7):1254-7. PubMed ID: 16957130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is dopamine agonist therapy associated with developing pathological gambling in Parkinson's disease patients?
    Zand R
    Eur Neurol; 2008; 59(3-4):183-6. PubMed ID: 18230877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease.
    Potenza MN; Voon V; Weintraub D
    Nat Clin Pract Neurol; 2007 Dec; 3(12):664-72. PubMed ID: 18046439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Impulse control disorders in Parkinson's disease].
    Joutsa J; Kaasinen V
    Duodecim; 2013; 129(22):2351-8. PubMed ID: 24397147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
    Avanzi M; Uber E; Bonfà F
    Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urinary disorders, sexual dysfunction and hypersexuality in Parkinson's disease].
    Vázquez-Sáánchez F; Rodríguez-Martínez E; Arés-Luque A
    Rev Neurol; 2010 Feb; 50 Suppl 2():S27-31. PubMed ID: 20205139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence and clinical characteristics of pathological gambling in Parkinson's disease: an evidence-based review.
    Barns Neurauter MP; Rickards H; Cavanna AE
    Funct Neurol; 2010; 25(1):9-13. PubMed ID: 20626992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication-related impulse control and repetitive behaviors in Parkinson disease.
    Voon V; Fox SH
    Arch Neurol; 2007 Aug; 64(8):1089-96. PubMed ID: 17698698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impulse control disorder and piribedil: report of 5 cases.
    Tschopp L; Salazar Z; Gomez Botello MT; Roca CU; Micheli F
    Clin Neuropharmacol; 2010; 33(1):11-3. PubMed ID: 19959959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impulse control and related disorders in Parkinson's disease: review.
    Lim SY; Evans AH; Miyasaki JM
    Ann N Y Acad Sci; 2008 Oct; 1142():85-107. PubMed ID: 18990123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.